on RedChip Companies, Inc. (Media Suite) (NASDAQ:JUNS)
60 Degrees Pharmaceuticals Hosts Investor Webinar
On October 22, 2025, RedChip Companies, Inc. will host a live investor webinar featuring 60 Degrees Pharmaceuticals, Inc. The session, scheduled for 4:15 p.m. ET, will spotlight CEO Geoffrey Dow. Discussions will center on the potential of ARAKODA® (tafenoquine), an FDA-approved antimalarial drug with expanding commercial presence in the U.S.
Dr. Dow will also discuss plans to extend FDA approval of tafenoquine for treating babesiosis, a tick-borne illness with growing prevalence. Currently, 60 Degrees Pharmaceuticals is conducting two clinical trials for babesiosis, with a third set to begin soon. Tafenoquine holds Orphan Drug status for this condition and patent exclusivity for malaria use through 2035.
A Q&A session will follow the presentation, allowing participants to engage directly with management. Interested parties can register for the free webinar online.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all RedChip Companies, Inc. (Media Suite) news